Vivakor (VIVK) Stock Price, News & Analysis

Company Overview

Vivakor, Inc. operates, acquires, and develops technologies and assets in the oil and gas industry and related environmental solutions in the United States and Kuwait. The company owns and operates a crude oil gathering, storage, and transportation facility in Delhi, Louisiana. It also owns a crude oil storage tank located near Colorado City, Texas. In addition, the company offers remediation of soil and the extraction of hydrocarbons, such as oil from properties contaminated by or laden with heavy crude oil and other hydrocarbon-based substances. The company was formerly known as NGI Holdings, LLC and changed its name to Vivakor, Inc. in April 2008. The company was incorporated in 2006 and is based in Dallas, Texas.

Key Stats

• Today's Range: $0.78 to $0.84
• 50-Day Range: $0.64 to $1.09
• 52-Week Range: $0.55 to $3.45
• Volume: 16,694 shs
• Average Volume: 61,639 shs
• Market Capitalization: $32.40 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VIVK Stock Analysis - Frequently Asked Questions

How have VIVK shares performed this year?

Vivakor's stock was trading at $1.22 at the beginning of 2025. Since then, VIVK shares have decreased by 35.2% and is now trading at $0.79.
View the best growth stocks for 2025 here.

When did Vivakor IPO?

Vivakor (VIVK) raised $8 million in an initial public offering (IPO) on the week of February 14th 2022. The company issued 1,500,000 shares at $4.50-$6.50 per share. EF Hutton acted as the underwriter for the IPO.

How do I buy shares of Vivakor?

Shares of VIVK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Vivakor own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Vivakor investors own include Meta Platforms (META), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), Artelo Biosciences (ARTL), Avenue Therapeutics (ATXI), AstraZeneca (AZN) and Constellation Energy (CEG).

Company Calendar

• Today: 4/03/2025
• Next Earnings (Estimated): 4/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Refuse systems
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:VIVK
• CIK: 1450704
• Web: vivakor.com
• Phone: (949) 281-2606
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.43)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-10,740,000.00
• Net Margins: -17.30%
• Pretax Margin: -16.62%
• Return on Equity: -66.05%
• Return on Assets: -14.70%

Debt

• Debt-to-Equity Ratio: 0.44
• Current Ratio: 0.10
• Quick Ratio: 0.09

Sales & Book Value

• Annual Sales: $61.99 million
• Price / Sales: 0.52
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.66 per share
• Price / Book: 1.20

Miscellaneous

• Outstanding Shares: 41,008,000
• Free Float: 21,390,000
• Market Cap: $32.40 million
• Optionable: Not Optionable
• Beta: 1.09